General Information of the Compound
Compound ID
CP0810328
Compound Name
7-(diethylamino)-3-(3-phenyl-1,2,4-oxadiazol-5-yl)-2H-chromen-2-one
    Show/Hide
Structure
Formula
C21H19N3O3
Molecular Weight
361.401
Canonical SMILES
CCN(CC)c1ccc2cc(-c3nc(-c4ccccc4)no3)c(=O)oc2c1
    Show/Hide
InChI
InChI=1S/C21H19N3O3/c1-3-24(4-2)16-11-10-15-12-17(21(25)26-18(15)13-16)20-22-19(23-27-20)14-8-6-5-7-9-14/h5-13H,3-4H2,1-2H3
    Show/Hide
InChIKey
JGGYVUDYCGHHIK-UHFFFAOYSA-N
Physicochemical Property
logP
4.3562
Rotatable Bonds
5
Heavy Atom Count
27
Polar Areas
72.37
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16034640
SID: 160641655
ChEMBL ID
CHEMBL1474248
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01286, Bile acid receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
EC50 = 460 nM
   TI
   LI
   LO
   TS